Gynaecology & Obstetrics General 5a30c0bd Roughly what percentage of patient with metastatic epithelial ovarian cancer will be benefited by treatment with an alkylating agent : A Less than 10 percent B 25 to 49 percent C 50 to 74 percent D 75 to 89 percent High-Yield Explanation 50 to 74 percent